REYGHAN ROSENDALE: Open Payments
NPI 1972231645 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 24 payments from 8 companies in 2025. Trend: 2023 $286 · 2024 $556 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $191 |
| Madrigal Pharmaceuticals | 7 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Lilly USA, LLC | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
Products named: REZDIFFRA, XIFAXAN, SKYRIZI, MAVYRET, RINVOQ, OMVOH, TREMFYA, EOHILIA.
Industry payments across OH — which companies pay providers there.
